D2C7-IT and 2141-V11 in Newly Diagnosed GBM Patients

Recruiting

Phase 1

Phase 2

D2C7-IT & 2141-V11D2C7-IT and 2141-V11 in Newly Diagnosed GBM Patients

Sponsor:

Darell Bigner

Code:

NCT05734560

Conditions

Newly Diagnosed MGMT Unmethylated Glioblastoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

D2C7-IT

2141-V11

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by Darell Bigner on 2025-03-25.